Russia has confirmed that it will soon be able to produce hundreds of thousands of doses of new vaccine a month for the new Corona virus, and several million since the beginning of next year.
According to CNBC Arabia, Russian Trade Minister Denis Manturov said that, as of September, three biomedical companies will be able to produce a vaccine that has been developed previously. Nikolai Gamalia Center for Epidemiology and Microbiology, in large quantities.
"We will be able to provide hundreds of thousands of doses per month this year, then several million at the beginning of next year," he told Tass News Agency.
The head of the Russian Fund for Direct Investment in Development, announced Monday that the official approval of the vaccine should take place within ten days.
Kirill Dmitriyev said in a television interview that we will advance not only to the United States but also to other countries. It will be the first recorded vaccine against the new SK.
Russia, like many other countries in the world, has been working for months on several projects for the Covid-19 epidemic vaccine. The Gamalia vaccine was developed in cooperation with the Ministry of Defense.
The ministry praised Monday, in a statement, clinical trials of military personnel who clearly demonstrated an apparent immune response against the Corona virus without registering any side effects or unusual.
The experimental vaccine being worked on is a viral vector as it is used as a substrate of another virus that has been converted and adapted to fight Covid-19. The technique for adenovirus use is also chosen by Oxford University.
Researchers expressed concern about the rapid development of Russian vaccines, and said that certain steps might be passed in order to speed up work under pressure from the authorities, and compared the race to reach a vaccine with the launch of the Federation Soviet Sputnik first space satellite in 1957.
Vitaly Zverev, a professor and head of a laboratory at the Michnikov Research Institute, told AFP that it is too early to certify a vaccine that has not been sufficiently tested to ensure its safety. p>
He continued, it is impossible to confirm the validity of a vaccine in a period of time such as that separating us from the beginning of the epidemic, adding that the Russian biomedical companies that are supposed to produce the vaccine were not usual. Moreover, neither is the advanced technology to be used.
NamaaZone " The Power of Knowledge"
